Security key
52886N406
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 1,701,197
- Total 13F value
- $1,053,042
- Share change
- -16,120
- SEC-reported price per share
- $0.62
- Number of holders
- 21
- Value change
- -$168,784
- Number of buys
- 9
- Number of sells
- 8
Report period
Q4 2025
Institutions
21
Top holders
10
LEXX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Lexaria Bioscience Corp. SEC filings
Lexaria Bioscience Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52886N406
Recent filing periods:
Ownership snapshot
Top reported holders of LEXX - Lexaria Bioscience Corp. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invenomic Capital Managem...
Disclosed value leader
Invenomic Capital Managem...
Comparable rows
0/15
Latest evidence
30 Sep 2025
13F
3/4/5
Highest disclosed value: $454,629
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Invenomic Capital Management LP has the largest disclosed position value at $454.6K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invenomic Capital Management LP's linked filing trail.
Disclosed position value
Top 5
Invenomic Capital Management LP
$454.6K
Murchinson Ltd.
$399.7K
Richard Christopher
$363.6K
John Martin Docherty
$322.5K
VANGUARD GROUP INC
$246.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invenomic Capital Management LP |
13F
Company
|
—
class O/S missing
|
$454,629
477,201 shares
|
— | 30 Sep 2025 |
| Murchinson Ltd. |
13F
Company
|
—
class O/S missing
|
$399,743
419,590 shares
|
— | 30 Sep 2025 |
| Richard Christopher |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$363,611
415,000 shares
mixed-class rows
|
— | 29 Jul 2025 |
| John Martin Docherty |
3/4/5
President & CSO, Director
|
—
mixed-class rows
|
$322,458
370,285 shares
mixed-class rows
|
— | 29 Jul 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$246,651
258,816 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$166,546
174,779 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
21
Shares
1,701,197
Rows available
21
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
25
Q4 2025 holders
21
Holder diff
-4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend